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 INTRODUCTION  
 Multinodular goitre is a frequently encountered problem in the surgical 
wards. Quite a large number of our patients reach us at a stage where the 
goitres are frequently massive, having perhaps contacted their private 
physicians, who are likely to have reassured them as to the relatively benign 
clinical course.  
 Multinodular goitres remain fairly heartening to treat, with the 
availability of a large number of skilled doctors to treat the disease with the 
least morbidity. 
 Controversy, however, does exist as to the best method to treat 
multinodular goitres adequately, especially in patients with toxic symptoms. 
The present study is an attempt to establish the incidence, analyse the 
symptomatology, modes of treatment and results in our patients.  
The aim was to study the following objectives in patients admitted with a 
diagnosis of multinodular  goiter.  
 AIM OF STUDY 
 The aim was to study the following objectives in patients admitted with 
a diagnosis of multinodular goiter at Government Royapettah  Hospital, 
Chennai. 
• To establish the incidence and the age preponderance.  
• To estimate percentage of patients presenting with toxicity. 
• To estimate the incidence of compressive symptoms. 
• To analysis the sensitivity and specificity of fine needle aspiration 
cytology. 
• To study the incidence of complications following subtotal 
thyroidectomy. 
 
 REVIEW OF LITERATURE 
Goitre is a worldwide disease and can be sporadic or endemic, the 
endemic variety being particularly high in alpine areas where glacial action has 
leached iodine from the soil and carried it away to the sea. These endemic 
goitres are rarely seen in the coastal areas. 
The multinodular goitre, on the often hand, occurs sporadically and tends 
to affect middle aged women. It may represent an acquired defect due to aging. 
Many multinodular goitres develop from simple goitres, especially if Iodine 
intake or availability is compromised. The initial diffuse hyperplastic process 
then becomes localized to one or several areas of disorganized thyroid 
metabolism in which the hyperplastic acini undergo colloid involution, while 
others show haemorrhage, cystic degeneration or necrosis. Fibrosis and 
calcification may then supervene. 
Patients with longstanding multinodular goitres often develop 
thyrotoxicosis, the exact incidence of which is variable. Excess thyroid 
hormones may be produced by the nodules themselves, by the paranodular 
tissue or by a combination of both. Eye signs are usually absent and cardiac 
arrhythmias and cardiac failure are more common than in Graves disease. 
APPLIED ANATOMY 
The thyroid is the largest endocrine organ,weighing approximately 30 
gms in average Indian adults. The potential for growth is however enormous. 
 The normal thyroid is made up of 2 lobes joined by a thin band of tissue, 
the isthmus. The latter is approximately 0.5 cm thick, 2 cm wide, 2 cm high. 
The individual lobes have a pointed superior pole and a poorly defined inferior 
pole merging medially with the isthmus. Each lobe is approximately 2 cm in 
thickness and 4 cm in length. Occasionally, a pyramidal lobe is discernible as a 
finger - like projection directed upwards from the isthmus, generally just lateral 
to the midline, usually on the left. The right lobe is normally more vascular 
than the left, is often the larger of the two, and tends to enlarge more in 
disorders associated with a diffuse increase in size. The lobes extend m the 
middle of thyroid cartilage above to the sixth tracheal ring below. Each lobe 
fills the space between the trachea and oesophagus medially and carotid sheath 
laterally. A strong condensation of an avascular connective tissue, known as 
the suspensory ligament of Berry, binds the gland firmly to h side of the cricoid 
cartilage. It is this ligament together with the tracheal fascia, which splits to 
invest the gland, which makes the thyroid move up and down on swallowing. 
The fascia, which is the false capsule, sends fibrous septa into the gland 
substance, dividing it into numerous lobules. Each lobule consists of 30 to 40 
follicles that contain colloid. 
 The vascular supply is via two paired arteries; a third vessel occasionally 
supplies the lower pole of one or other lobe. The superior thyroid artery, the 
first branch of external carotid artery runs downward on the inferior constrictor 
to reach the apex of the lateral lobe. The inferior thyroid artery arises from the 
thyrocervical trunk. Unnamed vessels arise from the oesophagus and trachea 
including the thyroidea ima artery, which may pass up from the aorta or 
brachiocephalic artery. 
The venous drainage is prone to variation. The superior thyroid vein: 
drains into the internal jugular vein. The inferior thyroid vein drains into the 
internal jugular vein or the brachiocephalic veins in the anterior mediastinum. 
The middle thyroid vein drains into the internal jugular vein. 
The lymphatic drainage from the upper part of the gland reaches the 
upper deep cervical lymph nodes either directly or through the prelaryngeal 
nodes. Lymph from the lower part of the gland drains into the lower deep 
cervical nodes directly, and also through the pretracheal and paratracheal 
nodes. G.Scott Williamson has described a very definite system of lymph 
vessels which leaves each lobe at the point of entrance of inferior thyroid 
artery, and passes directly into the lymph spaces of thymus. 
Important Anatomical Relationships 
1.  Recurrent Laryngeal Nerves 
The vagus, after entering the mediastinum, gives off the recurrent 
laryngeal nerve which returns to the neck after circling around the arch of aorta 
on the left and the right subclavian artery on the right, ascending in the 
tracheo-oesophageal groove. It enters the larynx posterior to cricothyroid 
articulation passing under or through Berry's ligament. The nerve may be 
non-recurrent in 0.25% cases and will be vulnerable to damage if the inferior 
thyroid arteries are routinely ligated laterally. The nerve supplies all the 
intrinsic muscles of larynx. At the level of upper border of isthmus, the nerve 
often divides into two. The anterior larger branch is the motor branch, and the 
posterior branch is only sensory to the larynx below the level of vocal cords. 
2.  The Superior Laryngeal Nerve 
 This nerve arises from the inferior ganglion of vagus and divides at the 
level of thyroid into a large internal laryngeal nerve, and a smaller external 
laryngeal nerve, which runs close to the superior thyroid artery. It supplies the 
cricothyroid, which is the tensor of the ipsilateral vocal cord. 
3.  Parathyroid Glands 
There are four parathyroids. The upper pair are situated above and 
medial to where the recurrent laryngeal nerve courses the inferior thyroid 
artery. The lower pair are situated within a 2 cm radius of the lower pole below 
and medial to the level where the recurrent laryngeal nerve crosses the inferior 
thyroid artery. 
PHYSIOLOGY 
The thyroid produces three hormones,, Thyroxine (T4), Tri 
-Iodothyronine (T3) and calcitonin. T4 & T3 are both stored in colloid, 
consisting primarily of thyroglobulin, which is an iodinated glycoprotein. 
Thyroglobulin stores are dependent on adequate dietary intake of iodine which 
is essential for T4, T3 synthesis. Iodine is derived from milk and dairy products 
with a small quantity coming from salt water fish and iodized salt. Iodides are 
absorbed by the stomach and upper gastrointestinal tract. Approximately one - 
third is trapped by the thyroid gland. A cytochrome reductase system generates 
a peroxidase enzyme which oxidizes the iodide to an active form. The activated 
iodide is bound covalently to tyrosine or monoiodotyro sine. Anti thyroid drugs 
prevent the iodide becoming trapped by inhibiting the peroxidase system within 
the thyroid. 
 The release of thyroid hormones from the colloid begins when the 
microvilli on the surface of thyroid cells engulf droplets of colloid. These then 
fuse with the lysosomes containing proteolytic enzymes, which hydrolyze the 
colloid. The iodotyrosines are rapidly converted to iodide and thyroxine, which 
enters the blood stream via the thyroid capillaries. A small quantity of 
unhydrolyzed thyroglobulin returns to the circulation via the thyroid lymphatic 
system. The iodide released from the thyroid contributes to a much larger 
circulating iodide pool than the dietary iodide pool. 
Thyroid stimulating hormone (TSH) produced by the thyrotrophic cells 
of the anterior pituitary control the complex enzymatic reactions that trap 
iodine,'convert it into T, T, and release them into circulation. When T3 & T, 
levels rise above the normal range, TSH production is shut down by a negative 
feedback. Release of TSH is regulated by thyrotrophin releasing hormone 
(TRH), which is produced by the hypothalamus. 
The role of calcitonin is unclear. It may be involved in the regulation of 
plasma calcium and phosphate concentration. 
FUNCTIONS OF THE THYROID HORMONES IN THE TISSUES 
 The Thyroid Hormones Increase the Transcription of Large 
Numbers of Genes. 
The general effect of thyroid hormone is to cause nuclear transcription of 
large numbers of genes. Therefore, in virtually all cells of the body, great 
numbers of protein enzymes, structural proteins, transport proteins, and other 
substances increase. The net result of all this is a generalized increase in 
functional activity throughout the body. 
Conversion of Thyroxine to Triiodothyronine and Activation of 
Nuclear Receptors. Before acting on the genes to increase genetic 
transcription, almost all the thyroxine is deiodinated by one iodide ion, thus 
forming triiodothyronine. This in turn has a very high binding affinity to the 
intracellular thyroid hormone receptors. Consequently, about 90 per cent of the 
thyroid hormone molecules that bind with the receptors is triiodothyronine, and 
only 10 per cent, thyroxine. 
The thyroid hormone receptors are either attached to the DNA genetic 
strands or in proximity to them. On binding with thyroid hormone, the 
receptors become activated and initiate the transcription process. Then large 
numbers of different types of messenger RNA are formed, followed within 
another few minutes and hours by RNA translation on the cytoplasmic 
ribosomes to form hundreds of new types of proteins. However, not all proteins 
are increased by similar percentages - some only slightly and others at least as 
much as sixfold. lt is believed that most, if not all, of the actions of thyroid 
hormone results from the enzymatic and other functions of these new proteins. 
Important Types of Increased Cellular Metabolic Activity 
The thyroid hormones increase the metabolic activities of all or almost all 
the tissues of the body. The basal metabolic rate can increase to 60 to 100 
percent above normal when large quantities of the hormones are secreted. The 
rate of utilization of foods for energy is greatly accelerated. Although the rate 
of protein synthesis is increased, at the same time the rate of protein catabolism 
is also increased. The growth rate of young people is greatly accelerated. The 
mental processes are excited, and the activity of most of the endocrine glands is 
increased. 
Effect of Thyroid Hormones on Mitochondria 
One of the principal functions of thyroxine might be simply to increase 
the number and activity of mitochondria, and they in turn increase the rate of 
formation of adenosine triphosphate (ATP) to energize cellular function. 
However, the increase in the number and activity of mitochondria could be the 
result of increased activity of the cells as well as the cause of the increase. 
When extremely high concentrations of thyroid hormone are 
administered, the mitochondria swell inordinately, and there is then uncoupling 
of the oxidative phosphorylation process with production of large amounts of 
heat but little ATP. Under natural conditions, it is questionable whether the 
concentration of thyroid hormones ever becomes high enough to cause this 
effect even in people who have thyrotoxicosis. 
Effect of Thyroid hormone in Increasing Active Transport of Ions 
through Cell Membranes. One of the enzymes that becomes increased in 
response to thyroid hormone is Na, K-ATPase. This in turn increases the rate of 
transport of both sodium and potassium through the cell membranes of some 
tissues. Because this process uses energy and increases the amount of heat 
produced in the body, it has been suggested that this might be one of the 
mechanisms by which thyroid hormone increases the body's metabolic rate. In 
fact, thyroid hormone also causes the cell membranes of most cells to become 
leaky to sodium ions, which further activates the sodium pump and further 
increases heat production. 
Effect of Thyroid Hormone on Growth 
Thyroid hormone has both general and specific effects on growth. For 
instance, it has long been known that thyroid hormone is essential for the 
metamorphic -change of the tadpole into the frog. In the human being, the 
effect of thyroid hormone on growth is manifest mainly in growing children. In 
those who are hypothyrold, the rate of growth is greatly retarded. In those who 
are hyperthyroid, excessive skeletal growth often occurs, causing the child to 
become considerably taller at an earlier age. However, the bones also mature 
more rapidly and the epiphyses close at an early age, so that the duration of 
growth and the eventual height of the adult may actually be shortened. 
An important effect of thyroid hormone is to promote growth and 
development of the brain during fetal life and for the first few years of 
postnatal life. If the fetus does not secrete sufficient quantities of thyroid 
hormone, growth and maturation of the brain both before birth and afterward 
an greatly retarded and the brain remains smaller than normal. Without specific 
thyroid therapy within days or weeks after birth, the patients remain mentally 
deficient throughout life. 
Effects of Thyroid Hormone on Specific Bodily Mechanisms 
Effect on Carbohydrate Metabolism. Thyroid hormone stimulates 
almost all aspects of carbohydrate metabolism, including rapid uptake of 
glucose by the cells, enhanced glycolysis, enhanced gluconeogenesis, increased 
rate of absorption from the gastrointestinal tract, and even increased insulin 
secretion with its resultant secondary effects on carbohydrate metabolism. 
Effect on Fat Metabolism. Essentially all aspects of fat metabolism are 
also enhanced under the influence of thyroid hormone. Because fats are the 
major source of long-term energy supplies, the fat stores of the body are 
depleted to a greater extent than are most of the other tissue elements. In 
particular, lipids are mobilized from the fat tissue, which increases the free 
fatty acid concentration in the plasma; thyroid hormone also greatly accelerates 
the oxidation of free fatty acids by the cells. 
 Effect on Plasma and Liver Fats. Increased thyroid hormone decreases 
the quantity of cholesterol, phospholipids, and triglycerides in the plasma, even 
though it increases the free fatty acids. 
Effect on Vitamin Metabolism. Because thyroid hormone increases the 
quantities of many of the enzymes and because vitamins are essential parts of 
some of the enzymes and coenzymes, thyroid hormone causes increased need 
for vitamins. Therefore, a relative vitamin deficiency can occur when excess 
thyroid hormone is secreted unless at the same time increased quantities of 
vitamins are available. 
Effect on Basal Metabolic Rate. Because thyroid hormone increase 
metabolism in almost all cells of the body, excessive quantities of the hormone 
can occasionally increase the basal metabolic rate to 60 to 100 per cent above 
normal. On the other hand, when no thyroid hormone is produced, the basal 
metabolic rate falls almost to one half normal; that is, the basal metabolic rate 
becomes - 30 to - 50. Extreme amounts of the hormones are required to cause 
high basal metabolic rates. 
 
Effect on Body Weight. Greatly increased thyroid hormone almost 
always decrease the body weight, and greatly decreased hormone almost 
always increases the body weight; these effects do not always occur because 
thyroid hormone increases the appetite, and this may overbalance the change in 
the metabolic rate. 
Effect on the Cardiovascular System 
Blood Flow and Cardiac Output. Increased metabolism in the tissues 
causes more rapid utilization of oxygen than normal and greater than normal 
quantities of metabolic end products to be released from the tissues. These 
effects cause vasodilatation in most of the body tissues, thus increasing blood 
flow. The rate of blood flow in the skin especially increases because of the 
increased need for heat elimination. 
As a consequence of the increased blood flow, cardiac output also 
increases, sometimes rising to 60 per cent or more above normal when 
excessive thyroid hormone is present and falling to only 50 per cent of normal 
in severe hypothyroidism. 
Heart Rate. The heart rate increases considerably more under the 
influence of thyroid hormone than would be expected from the increase in 
cardiac output. Therefore, thyroid hormone probably has a direct effect on the 
excitability of the heart, which in turn increases the heart rate. This effect is of 
particular importance because the heart rate is one of the sensitive physical 
signs that the clinician uses in determining whether a patient has excessive or 
diminished thyroid hormone production. 
Strength of Heartbeat. The increase enzymatic activity caused by 
increased thyroid hormone production apparently increases the strength of the 
heart when only a slight excess of thyroid hormone is secreted. This is 
analogous to the increase in strength of heartbeat that occurs in mild fevers and 
during exercise. However, when thyroid hormone is increased markedly, the 
heart muscle strength becomes depressed because of excessive protein 
catabolism. Indeed, some severely thyrotoxic patients die of cardiac 
decompensation secondary to myocardial failure and increased cardiac load 
imposed by the increased output. 
Blood Volume. Thyroid hormone causes the blood volume to increase 
slightly. The effect probably results at least partly from vasodilatation, which 
allows increased quantities of blood to collect in the circulatory system. 
Arterial Pressure. The mean arterial pressure usually is unchanged. 
However, because of the increased blood flow through the tissues between 
heartbeats, the pulse pressure is often increased, with the systolic pressure 
elevated in hyperthyroidism 10 to 15 mm Hg and the diastolic pressure reduced 
in a corresponding manner. 
 
Effect on Respiration. The increased rate of metabolism increases the 
utilization of oxygen and the formation of carbon dioxide; these effects activate 
all the mechanisms that increase the rate and depth of respiration. 
Effect on the Gastrointestinal Tract. In addition to increased appetite 
and food intake, thyroid hormone increases both the rate of secretion of the 
digestive juices and the motility of the gastrointestinal tract. Diarrhea often 
results. Lack of thyroid hormone can cause constipation. 
Effect on the Central Nervous System. In general, thyroid hormone 
increases the rapidity of cerebration but also often dissociates this; on the other 
hand, lack of thyroid hormone decreases this function. The hyperthyroid 
individual is likely to have extreme nervousness and many psychoneurotic 
tendencies, such as anxiety complexes, extreme worry, and paranoia. 
Effect on the Function of the Muscles. Slight increase in thyroid 
hormone usually makes the muscles react with vigor, but when the quantity of 
hormone becomes excessive, the muscles become weakened because of excess 
protein catabolism. On the other hand, lack of thyroid hormone causes the 
muscles to become sluggish, and they relax slowly after a contraction. 
 
Muscle Tremor. One of the most characteristic signs of hyperthyroidism 
is a fine muscle tremor. This is not the coarse tremor that occurs in Parkinson's 
disease or in shivering because it occurs at the rapid frequency of 10 to 15 
times per second. The tremor can be observed easily by placing a sheet of 
paper on the extended fingers and noting the degree of vibration of the paper. 
This tremor is believed to be caused by increased reactivity of the neuronal 
synapses in the areas of the cord that control muscle tone. The tremor is an 
important means for assessing the degree of thyroid hormone effect on the 
central nervous system. 
Effect on Sleep. Because of the exhausting effect of thyroid hormone on 
the musculature and on the central nervous system, the hyperthyroid subject 
often has a feeling of constant tiredness, but because of the excitable effects of 
thyroid hormone on the synapses, it is difficult to sleep. On the other hand, 
extreme somnolence is characteristic of hypothyroidism, with sleep sometimes 
lasting 12 to 14 hours a day. 
 Effect on Other Endocrine Glands. Increased thyroid hormone 
 increases the rates of secretion of most of the tissues for the hormones. 
For  instances, increased thyroxine secretion increases the rate of glucose 
metabolism everywhere in the body and therefore causes a corresponding need 
for increased insulin secretion by the pancreas. Also, thyroid hormone 
 increases many metabolic activities related to bone formation and, as a  
consequence, increases the need for parathyroid hormone. Finally, thyroid 
 hormone increases the rate at which adrenal glueocorticoids are 
inactivated by the liver. This leads to feedback increase in adrenocorticotropic 
hormone  production by the anterior pituitary and, therefore, increased rate of 
glucocorticoid secretion by the adrenal glands. 
Effect of Thyroid Hormone on Sexual Function. For normal sexual 
function, thyroid secretion needs to be approximately normal. In men, lack of 
thyroid hormone is likely to cause loss of libido; on the other hand, great 
excesses of the hormone frequently cause impotence. In women, lack of 
thyroid hormone often causes impotence. In women, lack of thyroid hormone 
often causes menorrhagia and polymenorrhea, that is, respectively, excessive 
and frequent menstrual bleeding. Yet, strangely enough, in other women 
thyroid lack may cause irregular periods and occasionally even amenorrhea. A 
hypothyroid woman, like a man, is likely to have greatly reduced libido. In the 
hyperthyroid women, oligomenorrhea, which means greatly reduced bleeding 
is common, and occasionally amenorrhea results. 
 The action of thyroid hormone on the gonads cannot be pinpointed to a 
specific function but probably results from a combination of direct metabolic 
effect on the gonads and excitatory and inhibitory feedback effects operating 
through the anterior pituitary hormones that control the sexual functions. 
PHARMACOLOGY OF THYROID 
A large number of compounds are capable of interfering, directly or 
indirectly, with the synthesis, release, or action of thyroid hormones. The major 
inhibitors may be classified into four categories: (1) antithyroid drugs, Which 
interfere directly with the synthesis of thyroid hormones; (2) ionic inhibitors, 
which block the iodide transport mechanism; (3) higher concentrations of 
iodine itself, which decrease release of thyroid hormones from the gland and 
also may decrease hormone synthesis; and (4) radioactive iodine, which 
damages the gland with ionizing radiation. 
Antithyroid Drugs 
The antithyroid drugs that have clinical utility are the thioureylenes, 
which belong to the family of thionamides. Propylthiouracil may be considered 
as the prototype. 
Mechanism of Action 
Antithyroid drugs inhibit the formation of thyroid hormones by 
interfering with the incorporation of iodine into tyrosyl residues of 
thyroglobulin; they also inhibit the coupling of these iodotyrosyl residues to 
iodothyronines. This implies that they interfere with the oxidation of iodide ion 
and iodotyrosyl groups. Taurog (1976) proposed that the drugs inhibit the 
peroxidase enzyme, thereby preventing oxidation of iodide or iodotyrosyl 
groups to the required active state. 
Over a period of time, the inhibition of hormone synthesis results in the 
depletion of stores of iodinated thyroglobulin as the protein is hydrolyzed and 
the hormones are released into the circulation. Only when the preformed 
hormone is depleted and the concentrations of circulating thyroid hormones 
begin to decline do clinical effects become noticeable. 
 In addition to blocking hormone synthesis, propylthiouracil inhibits the 
peripheral deiodination of thyroxine to triiodothyronine. 
 The antithyroid compounds are propylthiouracil and methimazole. 
Carbimazole (Neo-Mercazole), a carbethoxy derivative of methimazole, is 
available, and its antithyroid action is due to its conversion to methimazole 
after absorption. 
Untoward Reactions 
The most serious reaction is agranulocytosis. Agranulocytosis usually 
occurs during the first few weeks or months of therapy but may occur later. 
Patients should immediately report the development of sore throat or fever, 
which usually heralds the onset of this reaction. Agranulocytosis is reversible 
upon discontinuation of the offending drug, and the administration of 
recombinant human granulocyte colony - stimulating factor may hasten 
recovery. Other less frequent complications are pain and stiffness in the joints, 
paresthesias, headache, nausea, skin pigmentation, and loss of hair. Drug fever, 
hepatitis, and nephritis are rare, although abnormal liver functions tests are not 
infrequent with higher doses of propylthiouracil. 
Ionic inhibitors 
The term ionic inhibitors designates the substances that interfere with the 
concentration of iodide by the thyroid gland. The effective agents are 
themselves anions that in some ways resemble iodide; they are all monovalent, 
hydrated anions of a size similar to that of iodide. Thiocyanate, in large 
amounts inhibits the organification of iodine. 
Mechanism of Action 
 Acute inhibition of the synthesis of iodotyrosines and iodothyronines  by 
iodide is well known (the Wolff - Chaikoff effect). With time there is "escape" 
from this inhibition that is associated with an adaptive decrease in iodide 
transport and a lowered intracellular iodide concentration. The mechanism of 
the Wolff Chaikoff effect may involve inhibition of inositol phosphate 
signaling pathways within the thyrocyte. 
 A very important clinical effect of high plasma iodide concentration is 
an inhibition of the release of thyroid hormone. This action is rapid and 
efficacious in severe thyrotoxicosis. The effect is exerted directly on the 
thyroid gland, and it can be demonstrated in the euthyroid subject. 
Response to iodide in hyperthyroidism 
The response to iodides in patients with hyperthyroidism is often striking 
and rapid. The effect is usually discernible within 24 hours, and the basal 
metabolic rate may fall at a rate comparable to that following thyroidectomy. 
This provides evidence that the release of hormone into the circulation is 
rapidly blocked. After a variable period of time, the beneficial effect 
disappears. With continued treatment, the hyperthyroidism may return in its 
initial intensity or may become even more severe than it was at first. It is for 
this reason that, when iodide was the only agent available for the treatment of 
hyperthyroidism, its use was usually restricted to preparation of the patient for 
thyroidectomy. 
Therapeutic Uses 
Prior to surgery iodide is sometimes employed alone, but more frequently 
it is used after the hyperthyroidism has been controlled by an antithyroid drug. 
It is then given during the 7 to 10 days immediately preceding the operation. 
Optimal control of hyperthyroidism is achieved if antithyroid drugs are first 
given alone. If iodine also is given from the beginning, variable responses are 
observed; sometimes the effect of iodide predominates, storage of hormone is 
promoted, and prolonged antithyroid treatment is required before the 
hyperthyroidism is controlled. Strong iodine solution (Lugol's solution) is 
widely used and consists of 5% iodine and 10% potassium iodide, which yields 
a dose of 6.3 mg of iodine per drop. The iodine is reduced to iodide in the 
intestine before absorption. Saturated solution of p0assium iodide also is 
available, containing 38 mg per drop. Typical doses include 3 to 5 drops of 
Lugol's solution or 1 to 3 drops of saturated solution of potassium iodide 3 
times a day. 
Untoward Reactions 
Unpleasant brassy taste and burning in the mouth and throat, as well as 
soreness of the teeth and gums. Increased salivation is noted. Coryza, sneezing, 
and irritation of the eyes with swelling of the eyelids are common. Skin lesions 
are common, and vary in type and intensity. They usually are mildly acneform. 
and distributed in the seborrheic areas 
Radioactive iodine 
Chemical and Physical Properties. Although iodine has several 
radioactive isotopes, greatest use has been made of 131 I. It has a half-life of 8 
days, and, therefore, over 99% of its radiation is expended within 56 days. Its 
radioactive emissions include both y rays and P particles originate within the 
follicle and act almost exclusively upon the parenchymal cells of the thyroid 
with little or no damage to surrounding tissue. When small tracer doses of131 I 
are administered, thyroid function is not disturbed. However, when large 
amounts of radioactive iodine gain access to the gland, the characteristic 
cytotoxic actions of ionizing radiation are observed. Pyknosis and necrosis of 
the follicular cells are followed by disappearance of colloid and fibrosis of the 
gland. 
Therapeutic Uses 
Sodium iodide I "' is available as a solution or in capsules containing 
essentially carrier – free131 I suitable for oral administrations. Sodium iodide 
I131 is available for scanning procedures. Radioactive iodine finds its widest use 
in the treatment of hyperthyroidism and in the diagnosis of disorders of thyroid 
function. 
Indications 
The clearest indication for this form of treatment is hyperthyroidism in 
older patients and in those with heart disease. Radioactive iodine is indicated in 
patients with toxic nodular goitre, since the disease does not go into 
spontaneous remission. The risk of inducing hypothyroidism is less in nodular 
goitre than in Graves' disease, perhaps because of the normal progression of the 
latter and the preservation of nonautonomous thyroid tissue in the former. 
Usually, larger doses of radioactive iodine are required in the treatment of toxic 
nodular goitre than in the treatment of Graves' disease. 
The use of radioactive iodine during pregnancy is contraindicated; after 
the first trimester the fetal thyroid would concentrate the isotope and thus suffer 
damage, but even during the first trimester radioactive iodine is best avoided 
because there may be adverse effects of radiation on fetal tissues. 
 Diagnostic Uses. Tracer studies with radioactive iodine have found 
wide application in studies of disorders of the thyroid gland. Measurement of 
the thyroidal accumulation of a tracer dose is helpful in the diagnosis of the 
thyroid to TSH or to suppression by thyroid hormone. 
PATHOPHYSIOLOGY OF MULTINODULAR GOITRES 
Any comprehensive theory concerning the pathogenesis of multinodular 
goitres must take into account the pathogenesis and pathophysiology of simple 
goitres. 
These goitres probably represent a response to any of the several factors 
that impair the efficiency of thyroid in manufacturing adequate quantities of 
hormones. There is a hypersecretion of TSH leading to stimulation of thyroid 
growth and increase in the activity of the processes concerned with hormone 
biosynthesis that are capable of response. As a result of the increase in the 
thyroid mass and unit functional activity, a normal rate of hormone secretion is 
restored and the patient is eumetabolic but goitrous, associated perhaps with 
factors inhibiting normal iodine usage. Hyperstimulation or cycles of 
hyperstimulation and involution could lead to the emergence of areas of 
hyperplasia, possibly associated with functional autonomy, coupled with areas 
of exhaustion atrophy (involution), the whole mass made more heterogenous 
by areas of localized hemorrhage, fibrosis and sometimes calcification. This is 
perhaps due to local variations in thyroid microcirculation, as well as clonal 
differences between cells that give rise to thyroid follicles, some being more 
and some less responsive to TSH, and some autonomous from the outset. 
 With the passage of time, the quantity of autonomous functional tissue is 
sufficient to suppress the TSH-secretory mechanism. Initially this is manifest 
by subnormal response to TRH or lack of thyroid suppression during 
administration of exogenous hormone. Ultimately autonomous hyperfunction 
may be sufficient to produce thyrotoxicosis. 
In general, two patterns are seen. The first is a diffuse but somewhat 
uneven distribution of radioisotope that is altered little by the administration of 
exogenous thyroid hormone. Histopathological examination reveals multiple 
aggregates of small follicles with hyperplastic epithelium interspersed with 
variably sized nodules that appear as if they should be inactive. The second 
type of toxic multinodular goitre is also distinguished by its functional pattern. 
Here radioiodine becomes localized in one or more discrete nodules, while 
iodine accumulation in the remainder of the gland is suppressed. No further 
suppression is produced by exogenous thyroid hormone but TSH stimulates 
accumulation of iodine in the areas previously inactive. Histopathologically, 
the functioning areas resemble adenomas in being reasonably well demarcated 
from the surrounding tissue, consisting of large follicles consisting of 
hyperplastic epithelium, but the correlation of architecture with functional state 
is not good. The remaining issue appears inactive and zones of demarcation are 
present in both the functioning and non functioning areas suggesting that the 
areas that are functioning can do so without TSH and that the remaining areas 
retain their dependence on TSH, their function being suppressed as a 
consequence of hyperfunction of the autonomous zones. The extent of 
overproduction of T3 and T4 in toxic multinodular goitres is however, only 
mild. The radioiodine uptake is not greatly increased and may even be normal, 
and the Serum T3 and T4, levels are only marginally increased. 
PATHOLOGY 
 Grossly, the thyroid in enlarged and its shape is distorted, one lobe being 
frequently larger than the other. The thyroid capsule is stretched but intact. 
 Cross-section reveals multiple nodules, some surrounded by a partial or 
complete capsule. Secondary changes in the form of haemorrhage, 
calcification, cystic degeneration are common. 
Microscopically, there is a wide range of appearances. Some nodules are 
composed of huge follicles lined by flattened epithelium; others are extremely 
cellular or hyperplastic, and still others are predominantly or exclusively lined 
by Hiirthle cells. Some of the dilated follicles have a conglomerate of small 
active follicles at one pole (so called Sanderson's pollsters). Others have 
papillary projections facing the lumen of a cystic follicle, a feature that may 
lead to confusion with papillary carcinoma. 
It is not unusual to find within a nodule predominantly composed of large 
dilated follicles, sharply outlined solid or microfollicular clusters of follicular 
cells. It has been suggested that nodular goitres grow by episodic replication of 
these clusters which have been found to express immunohistochemically the 
P21 proto-oncogene product. The proliferative activity of these nodules can be 
estimated by immunostaining the sections with monoclonal antibody MIB-1. 
 Rupture of follicles leads to a granulomatous reaction to the colloid with 
appearance of histiocytes and foreign body-type giant cells. Areas of fresh and 
old haemorrhage, coarse fibrous trabeculation and foci of calcification are 
common. Occasionally osseous metaplasia may be seen. Greatly thickened 
vessels with calcified media may be present at the periphery. A variable 
number of chronic inflammatory cells are present in the ffIxoma in many of the 
cases indicating the coexistence of chronic thyroiditis. It is not possible to 
predict on the basis of the morphological appearance whether the patient has 
clinical or laboratory evidence of hyperthyroidism. 
Clinical Picture 
The clinical features of a non toxic goitre are those that result from 
thyroid enlargement. Most commonly, the effect is either merely disfiguring or 
is felt on a tightening of garments worn about the neck. With larger goitres, 
displacement or compression of oesophagus or trachea may occur, leading to 
dysphagia, a choking sensation or inspiratory stridor. Compression of the 
recurrent laryngeal nerve leading to hoarseness is unusual and would suggest 
carcinoma. Haemorrhage into a nodule or cyst produces acute painful 
enlargement locally, and if appropriately situated can enhance or induce 
symptoms of obstruction. Narrowing of the thoracic inlet may compromise the 
venous return from the head, neck and upper limbs sufficiently to produce 
venous engorgement, accentuated when the patient's arms are raised. 
 Toxic multinodular goitre is a common complication of its nontoxic 
precursor, but its precise incidence in the latter disorder is unknown . It usually 
occurs after the age of 50 years in patients who have had multinodular goitre 
for many years. It is many more times more common among women, and is 
almost never accompanied by infiltrative ophthalmopathy. The clinical 
manifestations tend to differ from those in dffise toxic goitre. Cardiovascular 
manifestations tend to predominate, possibly because of the age of the patients. 
These may include atrial fibrillation or tachycardia, with or without heart 
failure. Weakness and wasting of muscles are common. Emotional lability may 
be pronounced. Obstructive symptoms are more common than in Graves' 
disease. 
INVESTIGATIONS FOR THYROID DISORDERS 
 There is no substitute for good history taking, and careful clinical 
examination in the assessment of thyroid disorders. None of the available tests 
is infallible, and misleading results may be obtained especially if the patient is 
taking medicines or has altered physiology, for example - in pregnancy. 
I.  Tests of Circulating thyroid hormone levels: 
1. Serum. Free Thvroxine (T4) : 
Normal range 55 - 150 nmol/l 
 This measures the total protein-bound Thyroxine, and provided that the 
patient is not on any drug which may affect the serum levels of binding 
proteins, offers a good test for thyroid function. Low levels are seen in 
nephrotic syndrome, and false high levels are seen in pregnancy, and in patients 
taking oral contraceptives. 
 Some drugs like salicylates, competing for protein binding, may give 
false low levels. 
2. Serum Tri-iodothyronine (T3) 
Normal range 1.2 - 3.1 nmol/l 
The serum T3 levels are also affected by changes in the thyroid binding 
proteins and are therefore subject to the same limits of interpretation. Most 
useful for confirmation of hyperthyroidism, especially when clinical picture 
strongly suggests Thyrotoxicosis but the T4 levels are normal. 
3.  Free Thyroxine 
Normal range 8 - 26 pmol/l 
Using radioimmunoassay, can be done at low cost. Levels do not vary 
with age or due to drugs such as salicylates, phenytoin. 
4.  Free tri-iodothyronine 
Normal range 3 - 9 pmol/l 
The Free T3 imino radioimmunoassay has the same merit as Free T4 
assay. Best single test to assess hyperthyroidism. 
II.  Tests of Hypothalamic - Pituitary Function 
1.  Thyroid - Stimulating Hormone 
(Normal range 0.5 - 5 mmol / 1) 
New IRMA assays (Immunoradiometric assay) are useful to confirm both 
hypothyroidism and hyperthyroidism. 
2. Thyrotrophin - Releasing hormone Test 
Following the IV administration of 400 micrograms / 1.73 m2 of BSA of 
thyrotrophin, the patient's TSH levels are measured in blood samples taken at 
0,20,60 mins. 
In patients with hypothyroidism, exaggerated response in seen, while in 
patients with hyperthyroidism, little or no response is seen. 
III.  Dynamic Tests of Thyroid Function 
1.  Radioiodine Isotope Uptake 
 Uptake measurement combined with thyroid scanning is helpful in 
identifying which part of the gland is hyperfunctioning and in identifying the 
patients with thyroiditis who are clinically thyrotoxic but have low uptake. 
Factors that increase uptake: 
a)  Reflecting increased hormone synthesis. 
i) Hyperthyroidisin 
ii)  Response to glandular hormone depletion 
  Recovery from thyroid suppression 
Recovery from subacute thyroiditis 
Antithyroid drugs 
iii)  Excessive hormone losses 
Nephrosis 
Chronic diarrhoeal states 
Soyabean ingestion 
b)  Not reflecting increased hormone synthesis - 
i) Iodine deficiency 
  Dietary supply 
Excessive loss (dehalogenase deficiency, pregnancy) 
ii)  Hormone biosynthetic defects. 
Factors that decrease uptake. 
a)  Reflecting decreased hormone synthesis. 
i)  Primary Hypofunction 
Hashimoto's disease 
Subacute thyroiditis 
ii)  Secondary hypofunction 
iii)  Exogenous thyroid hormones. 
b)  Not reflecting decreased hormone synthesis: 
i)  Increased bioavailability of iodine 
Dietary or Pharmacologic supply 
Cardiac or Renal insufficiency 
ii)  Increased hormone release 
(rare) very severe hyperthyroldism 
IV.  Tests of Thyroid Dysfunctions 
Antithyroid Antibodies 
(antithyroglobulin and antimicrosomal antibodies). 
Very high tires of antithyroglobulin antibodies are seen in patients with 
Hashimoto's thyroiditis, especially in those with long standing disease, when 
their presence strongly supports the diagnosis. The presence of 
antithyroglobulin antibodies in a hyperthyroid patient with eye signs suggests 
Grave's disease. The presence of antimicrosomal antibodies indicates 
autoimmune thyroid disease of Hashimoto's type and when found in patients 
who have already received thyroxine makes a presumptive initial diagnosis of 
thyroid failure more likely. This antibody is also seen in patients with thyroid 
malignancy. 
Fine Needle Aspiration Cytology 
This technique promoted by the Karolinska Institute has only recently 
gained wider acceptance. A 25 gauge disposable needle on a 10 ml syringe 
enables cells to be aspirated from any suspicious areas of the thyroid. The 
procedure can be performed quickly and painlessly in the outpatient department 
without the need for a local anaesthetic, providing a smeared specimen which 
can be fixed and stained on a microsurgery shade. A high level of diagnostic 
accuracy can be achieved when the clinician and cytologist are experienced. 
The technique cannot distinguish benign from malignant follicular lesions since 
no information is available about capsular or vascular invasion. 
TREATMENT 
The treatment of a non toxic goitre depends on its cause and stage of 
development. If a pharmacological goitrogen is being given, its removal will 
suffice. If this is not useful, Levothyroxine may be administrated in 
replacement doses to interrupt the endogenous thyroid stimulation. 
This is more useful in younger patients where the serum TSH levels are 
normal or somewhat increased. In older patients with nodular goitres, the 
serum TSH concentrations are often less than 0.5 MuA even though serum 
thyroid hormone levels may still be in the normal range. In such patients 
further suppression of TSH is inappropriate and may lead to thyrotoxicosis 
resulting from a combination of both exogenous and endogenous hormone. 
 (Use of iodine is to deplored as it is ineffective and has a capacity to 
induce thyrotoxicosis) 
Indications for Surgery 
 Large goitres may well cause cosmetic disfigurement, pressure 
symptoms and discomfort. All of these are good indications for surgery, the 
extent of which is dependent on the size and number of nodules present. 
Following surgery a small dose of thyroxine reduces the risk of recurrence. In 
the elderly, a dose of 0.05 mg may be sufficient, to achieve an acceptable 
degree of TSH suppression. In addition, the possible exacerbation of 
osteoporosis with excessive thyroid hormone therapy must be kept in mind. 
There is considerable disagreement regarding the treatment of choice for 
most patients with multinodular goitre with toxicity. A marked preference for 
radioiodine exists in the North America, where experience indicates that the 
responsiveness to radioiodine of multinodular goitre differs little from that of 
diffuse toxic goitre, whereas it's use is more selective in United Kingdom and 
India. The type that responds to radioiodine may resemble diffuse toxic goitre 
in displaying a relatively diffuse accumulation of radioiodine. The more 
resistant variety, on the other hand may be associated with adenomatous 
hyperfunction; here the tissue previously suppressed may regain function and 
ultimately achieve autonomy after the hyperactive tissue has been destroyed. 
 Unfortunately the thyroid function of patients with large toxic 
multinodular goitres is often very labile during treatment with antithyroid drugs 
and relapse rates following withdrawal are greater than 50 percent. Radioactive 
iodine is also very unlikely to suit most patients as drug uptake is variable, 
there is minimal impact on the size of the gland, and response is slow. Surgery 
is best carried out sooner than later to avoid compromise of the airway and the 
cardiovascular system. The specific surgical procedure is subtotal 
thyroidectomy  i.e  removal of atleast 85% of the gland, notably those parts 
shown to be active on radioiodine scanning . Recent literature recommends   a 
total thyroidectomy for multinodular  goiters. 
The definitive treatment should be preceded by a course of antithyroid 
therapy until a eumetabolic state in achieved. After six to eight weeks the 
antithyroid drugs are gradually withdrawn, and if hyperthyroidism recurs, a 
second course of therapy should be given. 
Preoperative Measures 
Preparation is directed to ensure safe induction of anaesthesia and a 
trouble free intra and post operative course. Hemoglobin estimation, chest 
radiology and an ECG are mandatory. Blood transfusion is rarely required. 
Grouping and saving of serum is all that is required. The vocal cords should 
always be examined by indirect laryngoscopy. This is especially important 
when the voice is compromised, malignancy is suspected or when previous 
thyroid surgery has been undertaken. A small proportional of patients have 
unsuspected recurrent laryngeal nerve palsy. It is of medicolegal importance to 
both the patient and the surgeon to determine before surgery whether or not the 
vocal cords were moving normally. 
 Thyrotoxic patients need to be rendered euthyroid or the peripheral 
effects of high circulating levels of thyroxine blocked. The majority of 
thyrotoxic patients referred to surgery have already been started on antithyroid 
drugs. 10 days prior to operation, oral propranolol is started in a dose of 30 to 
120 mg every 6 to 8 hours. The dose is adjusted to keep the patients sleeping 
pulse at about 70 beats / min. Since the effective duration of action of 
propranolol is approximately 6 hrs, it is important to administer medication 
right up to induction of anaesthesia and to continue treatment thereafter, 
especially if the patient develops tachycardia. Propranolol is contraindicated in 
patients with bronchial asthma, sinus bradyeardia or congestive heart failure. 
Prompt treatment of the hyperthyroid state can often significantly reduce the 
cardiovascular symptoms. In elderly patients with apathetic hyperthyroidism 
especially, cardiovascular symptoms predominate. These individuals are 
resistant to cardiac glycosides. B-blockers can be administered orally or 
intravenously, but must be used with caution in patients with failure, but are 
beneficial if the failure is accompanied by tachycardia. Correction of the basic 
metabolic defect requires specific therapy directed at reducing the production 
of thyroid hormone. Iodides, and Propylthiouracil are useful in the rapid 
amelioration of the hyperthyroid state. Most hyperthyroid patients escape from 
the effects of iodine after 10 to 14 days. Patients on anti-thyroid drugs should 
have their blood counts checked regularly if reduced resistance to infection is 
suspected. 
 PATIENTS AND METHODS 
 This study was carried out on 49 patients of multinodular goitre in 
surgical wards of Government Royapettah Hospital, Chennai  from March 
2003 – August 2005. 
 Initial workup included clinical examination, hematological and 
biochemical parameters, radiological investigations. Routine ENT examination 
including indirect laryngoscopy was done. Ultrasonogram of the thyroid was 
done in selected cases. All cases had extensive cardiac evaluation including 
clinical evaluation, ECG and echocardiogram. FNAC was done for all patients. 
Patients were categorized into those with toxic symptoms and those 
without toxic symptoms. The patients with clinical and/or biochemical 
evidence of thyrotoxicosis were started - on antithyroid drugs viz. Tab 
.Carbimazole 5 mg t.d.s. and progressively increased till control of toxicity 
along with Tab.Propranolol 20 mg 6 hrly. All such patients had monitoring of 
sleeping pulses as an index of toxicity. 
Surgery was recommended for all patients with large goitres which were 
cosmetically disfiguring, which produced obstructive symptoms over their 
trachea or oesophagus, which were producing toxic symptoms (once the 
toxicity was reduced). 
 The specific surgical procedure performed was Subtotal thyroidectomy. 
Following surgery, histopathological examination was performed on all 
specimens. 
 Postoperative adjunct treatment was given in the form of L-Thyroxine 
tablets 0.1 mg tablet daily. Patients with preoperative toxicity were continued 
postoperatively on tab. Propranolol. The postoperative complications were 
recorded. 
 Patients were followed up after discharge for evidence of toxicity or 
hypothyroidism, or recurrence of symptoms. 
 
OBSERVATIONS 
Epidemiology 
 The sex incidence of our study showed that overwhelming majority of 
our patients with multinodular goitre were females. The ratio was 48 :1 in 
favour of females. 
 The age incidence showed a wide variation with the youngest patient 
being 16 years, and the oldest being 46 years with a mean age of 31 years. 
 The study revealed that only 6 of the 49 patients in our study had 
clinical or biochemical evidence of toxicity. The youngest of these patients was 
22 yrs with a mean age of 29.5 years. 
Socioeconomic Status 
 The socioeconomic status was more or less reflective of the usual input 
of patients of our hospital, the majority being from semi  skilled labourer class 
earning on an average 1000-1200 Rs. per month. 
Symptoms 
 All the patients in our study revealed that they are aware of the lump. 
39% of the patients (19/49) complained of difficulty in swallowing. 32% of the 
patients (16/49) complained of dyspnoea. Only 4 of the 49 patients (8%) 
complained of hoarseness. 17 of the 49 patient i.e. 35% of the patients 
complained of no symptom other than the swelling in the neck. All the six 
patients with toxicity had dyspnoea, palpitations. 
 The study of duration of symptoms of these patients revealed that some 
patients consulted their physicians within 4 months of onset of symptoms while 
others waited as long as 6 years, with the mean at 1½ years. 
Past History 
 The past history of none of these patients was contributory to their 
symptoms. 2 patients had treatment for pulmonary tuberculosis, 4 of the 
patients were hypertensive, but were  not associated with hyperthyroidism: 
None of the patients gave any history of irradiation to the neck. 
Personal Habits 
 46 of these 49 patients consumed mixed diet: all of them consumed sea 
food. 
 44 patients used rock salt at home. Only 2 patients could specify that 
they use iodized salt. 
 2 patients with toxicity had disturbances of their menstrual cycles. 
Signs 
 All the glands were found to be involved in both the lobes, the number 
of nodules variable. All the toxic patients exhibited tremors and tachycardia. 
The gland was vascular, with palpable thrill and an auscultable bruit in each of 
them.  
Fine Needle Aspiration Cytology : 
 All the patients had FNAC of their thyroid swellings done. All the 
cytology reports revealed the cells to be from goitrous lesions. 
Adjunct Investigations 
 Radioiodine uptake study and scanning of the thyroid was not done as a 
routine measure in view of its non-availability at our hospital. Only those 
patients who had clinical evidence suspicious of toxicity had RAIU and 
scanning. 6 of the 49 patients had this study, 
 ECG and Echocardiogram was done in all the patients. None of the 
patients with toxicity were in failure. There were no cases with atrial 
fibrillation.  
 USG thyroid was done in 10 of the 49 patients and  identified cystic 
lesions in 6 of these 10 cases, none of whom were toxic. 
 Biochemical markers for hyperthyroidism i.e. serum T3, T4, TSH assays 
were contributory in 6 patients.  
Preoperative Workup 
 All the patients had ENT examinations and indirect laryngoscopy was 
performed in all the patients. All the patients were assessed for subtotal 
thyroidectomy under general anesthesia. The patients with clinically or 
biochemically proven hyperthyroidism were started on Tab. Neomercazole 5 
mg tds dosage along with Tab. Propranolol 40m g bds dosage. The dosage was 
adjusted to achieve a target of sleeping pulse rate around 70  beats/m. This 
involved  an average waiting period of over eight weeks. 3 of the patients with 
toxicity had Lugol’s iodine for 10 days preoperatively.  
Operative Findings 
 All patients underwent subtotal thyroidectomy, under general 
anaesthesia. 
 The parathyroids were preserved in all cases. 
 The recurrent laryngeal nerve was identified in 30 of the 
thyroidectomies as a deliberate attempt to preserve it during the course of the 
operation. 
 The blood loss was found to be appreciably more in patients with 
toxicity. There appeared to be not much difference due to preoperative Lugol’s 
iodine. Five of the 49 patients needed blood transfusion (including 4 of the 
patients with toxicity). The vocal cords were inspected routinely at the end of 
the operation. There  was no paralysis in any case. All patients had a drain from 
the inferior aspect of their wound.  
Postoperative Sequelae 
 37 of the 49 patients had uneventful postoperative periods.  
 Three patients developed hoarseness of voice, which corrected itself by 
the 2nd postoperative day in all patients.  
 Subcutaneous edema developed in 3 patients who had subcuticular 
sutures which subsided spontaneously by the 3rd postoperative day. 
 One patients developed toxicity on the first night after the operation, 
which subsided with antithyroid drugs and β-blockers.  
 All patients had their sutures removed by the 6th Postoperative day. 
 There was no mortality in our group of 49 patients. There was no wound 
infection. 
Histopathology 
 All the specimens were sent for histopathological examination. 43 of 49 
specimens were confirmed to be multinodular goitre.  
 3 specimens were reported as Hashimoto’s thyroiditis. 
 2 specimens were reported as multinodualr goiter with foci of papillary 
carcinoma.  
 1 specimen was reported as follicular carcinoma. 
Followup 
 All the patients were advised Tab. Eltroxin 0.1 mg, daily as a 
replacement dose. The patients with preoperative hyperthyroidism were asked 
to  continue  tab propranolol for 1 week post operatively. Although all the 
patients were advised regular followup, only 7/49 patients do so regularly.  
DISCUSSION 
The results of the present study reflect the pattern of multinodular goiter 
treated in our hospital. 
The multinodular goiter showed a very definite female predilection, as 
with other studies. The highest incidence was found in the group of patients age 
20 – 35 years. This suggests that our patient are affected atleast a decade or two 
earlier than the patients in Western series. 
In contrast to Western literature, patients with multinodular goiter with 
toxicity in India tend to present at an early age. This study showed that average 
age of the toxicity in our study was 29 years. In West, this figure is about 50 
yrs. 
Majority of our patients belong to the low socioeconomic group. This 
may reflect the usual input of patients to our hospital. No specific factor related 
to the socioeconomic status of the patent appeared to be related to the 
appearance of multinodular goiter in our patients. 
Several studies have attempted to establish the actiological role of 
various food items in multinodular goiters. A det rich in derivatives of the 
vegetables of the brassicae family viz – cabbage, has been implicated. A 
deficiency of iodine as the cause of the goiter has long been speculated. Diet 
rich in seafood has always been considered protective. Almost all our patients 
consumed a mixed diet, sea food being a fairly common constituent of their 
diet. The majority of patients however did not use iodized salt. Indeed, a large 
proportion were not aware of iodized salt. There was no specific increase in 
consumption of the vegetables of the Brassicae family in our group which 
could constitute a cause for their goiters. Pharmacologic products have 
occasionally been implicated in the causation of goiters. Drugs like iodides, 
phenytoin, PAS, amiodarone are known to be goitrogenic. None of our patients 
however had any chronic intake of a goitrogen that could have been the cause 
of their symptoms. 
Our study of the symptomatology revealed that all our patients were 
aware of the swelling in the neck, either noticed by themselves, or brought to 
their notice by others. Quite a few of these patients however, did not 
immediately seek attention; indeed some patients went for as long as 6 yrs with 
the enlarging swelling without consulting a doctor. Eventually when they did 
approach a doctor, greater than half of them had troubling symptoms such as 
dysphagia accompanying the goiter. The symptomatology accompanying the 
goiter were particularly distressing to patients with hyperthyroidism. All of 
them complained of palpitation and dyspnoea. Most of them had tremors and 
gave a history of weight loss despite adequate appetite. Hoarseness was 
complained of by only 4 of our patients, none of whom had any evidence of 
vocal cord involvement, suggesting that it was likely to be due to pressure 
effect. This is in keeping with the published literature, which suggests that 
hoarseness in more common in malignant thyroid disease. 
All the patients had readily palpable goiters with nodules. The 
manifestation of symptoms of secondary thyrotoxicosis has been fairly 
impressive, all the patients with toxicity having tachycardia and high sleeping 
pulse rates. All these patients had glands which exhibited signs of high 
vascularity. 
β - blockers are known to be of great advantage in decreading the signs 
of toxicity. The use of Tab. Propranolol helped to bring down the toxicity 
considerably along with the use of Tab. Neomercazole (Casrrbimazole). 
The sleeping pulse rate has been found to be a reliable index of toxicity. 
Fine needle aspiration cytology continues to be a very useful tool, but 
has its limitations. All patients with a clinical diagnosis of multinodular goiter 
had an FNAC preformed. All the patients who had cytology smears suggesting 
goitrous lesion were studied. The eventual correlation with histopathological 
examination indicated that FNAC was accurate in 45 of the 49 patients, but 
could not defect follicular neoplasm in one patient. Three others who were 
initially though to lave multinodular goiter turned out to have Hashimoto’s 
disease. thus FNAC is useful in  multinodular goiter to rule out the presence of 
the neoplasm, especially papillary, and to suggest if a particular thyroid 
swellings is cystic or has solid and cystic components or only solid. 
In cases with borderline hyperthyroidism, investigations like radioactive 
iodine uptake and serum T3, T4, TSH may be necessary. We found the serum 
T3, T4, TSH level correlate well with the thyroid activity, and helped to rule out 
toxicity in two patients, and confirming toxicity in four others. The 24 hrs 
radioiodine uptake also correlated well with the toxicity in our patients, and 
was over 40% in 2 of the six patients with toxicity in whom it was done. 
Surgical procedure for goiter should be based on anatomical 
consideration, knowledge of for natural history of the disease and specific 
surgical goals in each  case. Our goal in doing subtotal thyroidectomy for 
patients without toxicity was to remove as much of the goiter as possible 
including all nodular tissue. In patients with toxicity, Sibtotal thyroidectomy 
was done, aiming to leave behind approximately 4 – 5 gms of thyroid tissue of 
each lobe. The Recurrent Laryngeal nerves were identified in 30 of our 
patients, and not identified in 19 of our patients. None of these patients had any 
vocal cord involvement postoperatively, suggesting that it is not necessary to 
look for recurrent laryngeal nerve in every case of subtotal thyroidectomy to do 
a safe surgery. The blood loss was significantly higher in patients with 
preoperative thyrotoxicosis. 
 
The study the of postoperative complication rates revealed that most of 
our patients had an uneventful postoperative period. Wound infection was not 
recorded even in one case, and the policy of keeping a drain appears to have its  
use, none of our patients ever developing a hematoma postoperatively. 
Transient suture line edema developed in patients with subcuticular sutures.  
One patient developed transient thyrotoxicosis in the first  
24 hrs postoperatively, and was managed with ice cold sponging,  
β - blockers and antithyroid drugs and hydrocortisone, possibly reflecting a 
release of  performed hormone into the circulation during the handling of the 
gland during the operation.  
Thus, the complication rates of surgery in our study are very much in 
line with those recorded in literature. There was no mortality, as should be 
expected. 
The histopathology examinations confirmed our clinical impressions in 
most patients. Three patients turned out to have Hashimoto’s disease and will 
require life long replacement therapy with Tab. thyroxine. Three  patients with 
differentiated thyroid carcinoma, were referred to Dept. of Radiation Oncology 
for further management. 
 
SUMMARY AND CONCLUSIONS 
• Multinodular goiter occurred most commonly between the third and 
fifth decades of life. Over whelming majority of our patents are 
female. Patients consuming a diet low in iodine seem to be 
susceptible to this disease. 
• Our patients tend to present fairly late – 3 after the onset of the 
symptoms. Patients with toxicity tended to present earlier. 
• Most common symptoms in our study were lump, lump with 
dysphagia, lump with dyspnoea, lump with dysphagia and dyspnoea. 
• Hoarseness was unusual as a primary symptom, and was seen in 
only 8% of our patients. 
• Pain was unusual among our patient occurring in only 12% of the 
patients. 
• 14% of our patients had documented hyperthyroidism. The serum 
T3, T4, TSH, and the radioiodine Isotope uptake were both useful in 
confirming the presence of hyperthyroidism. 
• Fine Needle Aspiration Cytology is a good, inexpensive, safe 
investigation with a sensitivity of 93%. 
• Surgery is an excellent modality of treatment, and can be performed 
with minimum morbidity and nil mortality. 
• Patients with hyperthyroidism will need preoperative normalization 
of their thyroid status with antithyroid drugs and β - blockers. 
• Most common histopathology examination result appears to be 
multinodular goiter with degenerating nodules. 
• Regular follow up is essential, to look for occurrence of 
hypothyroidism. 
Multinodular goiter is a common clinical entity. With the best of 
technology and skilled surgical care available today, it should be possible to 
relieve the patients of their symptoms with least morbidity. Surgery is an 
excellent modality of treatment. Regular follow up of the patient is essential 
after the definitive treatment. 
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MULTINODULAR GOITRE - PROFORMA 
Name  
Age  
Sex  
Address  
Occupation 
Socioeconomic Status  
I.P. No. 
Symptoms 
1. Duration 
2. Lump in the neck 
3. Discomfort on swallowing 
4. Dyspnoea 
5. Hoarseness of voice 
6.  Symptoms of hyperthyroidism or hypothyroidism 
  sweating, tremors, sleep disturbance, appetite alteration, 
  weight alteration, alteration in bowel motility, 
  palpitations, proximal muscle weakness, menstrual 
  disturbances. 
Past History 
 Radiation 
 Drugs 
 Others 
 Family History 
Personal History 
 Diet, (including iodized salt) 
 Sea food intake 
 
General Examination 
1. Nervous appearance 
2. Sweaty palms 
3. Tachycardia 
4. Hypertension 
5. Eye signs 
 
Local Examination: 
1. Bilateral Involvement 
2. Palpable thrill 
3. Auscultable, bruit 
 
Systemic Examination: 
1.  Cardiovascular system 
2.  Respiratory system 
3.  Abdomen 
4.   Central Nervous system 
Investigations: 
1.  Blood Parameters 
2.  Biochemical Parameters 
3.  X-ray chest 
4.  X-ray neck 
5.  Indirect Laryngoscopy 
6.  FNAC 
7.  ECG and Echocardiogram 
8.  USG thyroid 
9.  Serum T3, T4, TSH 
10.  RAIU 
 
Operative : 
Findings 
Identification of Recurrent Laryngeal nerve 
Parathyroids 
Blood loss, needing transfusion. 
Histopathology: 
Sequelae: 
 Early 1. Hoarseness 
   2. Haematoma 
   3. Hyperthyroidism 
   4. Hypocalcemia 
   5. Mortality 
 Late 1. Recurrent nodule 
   2. Toxicity 
   3. Hypothyroidism 
 
Follow up: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A  PATIENT WITH MULTI NODULAR GOITRE 
 
 
 
 
 
 
A  PATIENT WITH MULTI NODULAR GOITRE 
  
 
SKIN INCISION  
 
 
 
 
RAISING OF SUB PLATYSMAL FLAP 
 
 
 
 
 
 
SECURING THE MIDDLE THYROID VEIN 
 
 
 
 
LIGATION OF SUPERIOR PEDICLE  
 
 
 
 
 
 
THYROIDECTOMY IN PROGRESS  
 
 
 
 
POST THYROIDECTOMY - INTACT RLN 
 
 
 
 
 
 
APPROXIMATION OF THE STRAP MUSCLES  
 
 
 
 
 
SPECIMEN 
 
 
 
 
S. 
No. Name Age IP Dur Lump Dysph Dyspn Hoarseness Biochem RAIU Toxic Treat Postop HPE
1 Kavitha 22 762228 6 M + - - - - - - STT UE MNG
2 Malar 25 765616 2 Y + + - - - - - STT Edema Foll. Ca
3 Selvi 24 766170 8 M + - - - - - - STT UE MNG
4 Shanthi 30 771781 1.5 Y + + + - + + + AT+STT Toxicity MNG
5 Sujatha 31 774800 6 M + - - - - - - STT UE MNG
6 Amudha 28 777164 10 M + - - - - - - STT Hoarse MNG
7 Latha 30 778109 1 Y + + - - - - - STT UE Degen MNG
8 Prema 32 779005 4 M + + - - - - - STT UE MNG
9 Sundari 35 780168 6 M + - - - - - - STT UE Degn MNG
10 Kalaiselvi 32 780194 2 Y + - + - - - - STT Edema Hashimotos
11 Raja 30 780214 4 Y + + + - + + + AT+STT UE Treated MNG
12 Lakshmi 22 782164 1 Y + - + - + + + AT+STT UE MNG
13 Gandhimathy 40 783175 4 M + - - - - - - STT UE MNG
14 Meena 36 784261 5 M + - + - + + + AT+STT UE Degn MNG
15 Panchalai 41 784316 6 Y + + + - - - - STT UE Degn MNG
16 Kasthuri 36 784960 2 Y + + - - - - - STT UE Degn MNG
17 Gayathri 24 785160 1.5 Y + - - - - - - STT UE MNG
18 Solai 41 786461 1 Y + + - - - - - STT UE MNG
19 Megala 45 787146 6 M + + - - - - - STT UE Degen MNG
20 Nalini 32 788106 8 M + - - - - - - STT UE MNG
21 Linda 26 789171 1 Y + + - - - - - STT UE MNG
22 Muniammal 46 789673 1.5 Y + - + - - - - STT UE MNG
23 Bhavani 24 790166 8 M + + - + - - - STT UE Hashimotos
24 Ambika 26 791684 1 Y + - - - - - - STT UE Foll. Ca
25 Nalini 22 792614 8 M + + - - - - - STT UE MNG
26 Mangammal 41 792656 6 M + - - - - - - STT UE MNG
27 Muthammal 44 793167 1.5 Y + + + + - - - STT UE MNG
28 Vadivazhagi 24 794657 2 Y + - + - - - - STT UE T.it is
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S. 
No. Name Age IP Dur Lump Dysph Dyspn Hoarseness Biochem RAIU Toxic Treat Postop HPE
29 Devaki 31 795168 3 Y + - - - - - - STT UE Degen MNG
30 Rani 28 796169 4 M + - + - - - - STT Hoarse MNG
31 Sulochana 34 796646 9 M + + + - - - - STT UE MNG
32 Jagadambal 42 796816 1 Y + + + + - - - STT UE MNGPap. Ca
33 Prameela 26 796960 1.5 Y + - - - - - - STT UE T. it is
34 Ranganayaki 34 797016 6 M + - + + + + + AT+STT Hoarse MNGPap. Ca
35 Chellammal 35 797611 2 Y + + + - + + + AT+STT UE Degen MNG
36 Vadivammal 40 797819 1 Y + - + - - - - STT UE MNG
37 Chittammal 38 799104 1 Y + + - - - - - STT UE MNG
38 Shakunthala 26 799690 5 Y + - - - - - - STT Edema Degen MNG
39 Jagadha 24 799909 1.5 Y + + + - - - - STT UE Hashimotos
40 Rosy 16 800691 2 Y + - - - - - - STT UE MNG
41 Mumtaj 34 810961 6 M + - - - - - - STT UE Degen MNG
42 Selvamery 26 815614 8 M + - - - - - - STT UE MNG
43 Sulthana Begum 40 819561 1 Y + - - - - - - STT UE MNG
44 Meena 25 820156 2 Y + - - - - - - STT UE MNG
45 Susheela 29 820619 1 Y + - - - - - - STT UE MNG
46 Viji 26 820118 1 M + - - - - - - STT UE MNG
47 Girija 30 821168 7 M + - - - - - - STT UE MNG
48 Punitha 31 821170 1 Y + - - - - - - STT UE MNG
49 Ramya 29 821179 3 Y + - - - - - - STT UE MNG
IP  : Inpatient Number;   Bio. Chem. : Serum T3, T4, TSH assay;  RAIU : Radioiodine Uptake;  STT : Subtotal thyroidectomy;  AT : Antithyroid Drugs;  
UE : Uneventful;  HPE : Histopathology;  MNG : Multinodular Gotire; Post Operative Sequel;  Treat : Treatment given;  Toxic : Toxicity;         
Dur : Duration;  Dysph : Dysphagia;  Dyspn : Dyspnoea;  T. itis : Lymphocytic thyroiditis;  Degen MNG : Degenerating Goitre; Foll. Ca : Follicular carcinoma;  Pap. Ca : Papillary 
Carcinoma;  Hoarse : Hoarseness
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